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Abstract 
Background: Inflammatory cytokine is important in modulating injured diseases. Tumor necrosis factor-α (TNF-α), 
one of potent inflammatory cytokines, plays a dominant role in host defense reaction. However, the concrete effect of 
TNF-α on acute liver injury is totally unclear. Here we reported the concrete effect and possible mechanisms of TNF-α 
on acute liver injury induced by carbon tetrachloride (CCl4).
Methods: SD male rats were equally divided into nine groups. CCl4 (1 ml/kg) was subcutaneously injected into the 
rats. Enbrel, a TNF-α inhibitor, were intraperitoneally injected at dose of 0, 0.25, 0.5, 1, 2, 4 or 8 mg/kg 15 min before 
the CCl4 injection. 24 h later, rats were sacrificed. Serum ALT and AST were measured with an autoanalyzer. Serum 
TNF-α were measured by ELISA. HE staining was used to observe the liver tissue morphology. Hepatocellular apopto-
sis were tested by immunochemistry and Tunnel kit. Inflammatory factors, involve IL-4, IL-6, IL-8, IL-β and IFN-γ were 
detected by RT-PCR. The NF-κB signal pathway and anti-apoptotic genes include Bcl-XL, FHC, XIAP and Bcl-2 were 
measured by western-blotting and RT-PCR.
Results: The change of liver function presented an obvious “V” shape in the whole process of persistently increased 
Enbrel. As Enbrel was increased gradually from 0 to 1 mg/kg, serum TNF-α were blocked, ALT and AST were gradually 
decreased as TNF-α as well as the numbers of hepatocellular apoptosis, and were declined to the minimum at 1 mg/
kg Enbrel. As Enbrel was increased gradually from 1 to 8 mg/kg, ALT, AST and hepatocellular apoptosis were increased 
instead, and reached to the maximum at 8 mg/kg Enbrel. HE showed that the seriousness of hepatocellular steatosis 
was the most at 8 mg/kg Enbrel, and second at 0 mg/kg, the weakest at 1 mg/kg in the acute liver injury. Western-
blotting and RT-PCR showed NF-κB, p-IκBα and antiapoptotic genes include Bcl-XL, FHC, XIAP, Bcl-2 were decreased as 
TNF-α was blocked by increased Enbrel.
Conclusion: Our results suggested that TNF-α had a dual role in acute liver injury. It was regulated might via the 
corporate effect of NF-κB signal pawahway and anti-apoptosis. Meanwhile, our findings provide a reference for clinical 
treatment of acute liver injury.
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Background
Liver is a specialized organ in terms of its metabolic, syn-
thetic and detoxifying function. It is a vulnerable organ 
as various noxious agents can be assimilated by intestine 
and transported into liver, inducing inflammation, necro-
sis, fibrosis, cirrhosis [1] and eventually hepatocellular 
carcinoma (HCC). Hepatic ischemia–reperfusion injury 
[2], endotoxemia [3], obstructive cholestasis [4], alcoholic 
hepatitis [5], halothane hepatitis [6], and hemorrhagic 
shock [7] can cause liver injury. Over 80 % of HCCs occur 
in patients with hepatic cirrhosis or fibrosis and thus 
develop in a setting of hepatocellular injury, regenera-
tion, infiltration of inflammatory cells and an abundance 
of activated myofibroblasts [8]. Despite different reasons, 
initiation of hepatocellular injury is the key to the com-
mon pathogenesis described previously, which in the 
long run promote the development of hepatic fibrosis 
and HCC [9]. Unfortunately, at present, the exact mech-
anisms of liver injury are still under study and yet, the 
treatment for liver injury is still a big problem to human. 
Carbon tetrachloride (CCl4), a kind of hepatotoxin, can 
effectively duplicate liver injury model caused by its pro-
duction of cytochrome P450 and the binding reaction 
with intermediate metabolites [10, 11]. It provides ben-
eficial foundation for further studying liver injury.
However, in the pathological process of liver injury, 
numerous inflammatory cytokines are significantly 
upregulated, such as tumor necrosis factor-α (TNF-α), 
which mediate inflammation and repair in physiologi-
cal conditions [12]. Tumor necrosis factor-α is a mul-
tifunctional pro-inflammatory cytokine that regulates 
multifarious processes including inflammation, cellular 
apoptosis, coagulation, metabolism, insulin sensitiv-
ity, tumor growth and invasion, and vascular functions 
[13–17]. Normally, TNF-α is required for hepatocyte 
proliferation during liver regeneration induce the tran-
scription factor nuclear factor-κB, which has protective 
effects [18]. After injury, even when no infectious agents 
are present, TNF-α quickly migrate into the injured tis-
sue after vasodilatation and suppress further cell death, 
activate stem cells, and promote epithelial proliferation 
[19]. However, on the other hand, some literatures have 
reported TNF-α paly a malignant role in the injured 
liver. It triggers a series of intracellular events that result 
in activation of apoptosis and accelerating hepatic cells 
death during liver injury [20]. And elevated serum levels 
of TNF-α in liver injured patients correlate with a detri-
mental prognosis [20, 21].
Despite current knowledge of TNF-α, litter is reported 
the concrete role of TNF-α in acute liver injury. Moreo-
ver, the influence of different concentration of TNF-α 
mediated by Enbrel (Etanercept), which is a genetically 
engineered fusion protein that can bind and inactivate 
TNF-α [22], on CCl4-induced acute liver injury remains 
largely unknown. Our present study is designed to deter-
mine the concrete effect of TNF-α on acute liver injured 
model induced by CCl4 and possible mechanisms associ-
ated with it.
Results
TNF‑α performs protective and harmful effects 
in CCl4‑induced acute liver injury
To investigate the effects of TNF-α on acute liver injury, 
different doses of Enbrel were pretreated 15  min before 
CCl4 administered. Serum alanine aminotransferase (ALT) 
and aspartate transaminase (AST) were significantly ele-
vated after subcutaneous injection of CCl4. The ALT and 
AST levels were all decreased pre-treated with Enbrel of 
0.25, 0.5 and 1 mg/kg when the serum TNF-α was slightly 
blocked (Fig. 1c) in CCl4-induced liver injured rats (Fig. 1a, 
b). Our data suggested ALT had 62 % reduction and AST 
had 33 % reduction as Enbrel was added from 0 to1 mg/kg. 
The serum ALT and AST were dropped to the minimum 
at 1 mg/kg Enbrel. It implied that TNF-α had some dam-
aging effect in acute liver injury, and appropriately down-
regulated TNF-α level would alleviate the injury. However, 
as TNF-α was sequentially blocked at high dose of Enbrel 
(4 and 8  mg/kg), the ALT and AST levels were increased 
instead and reached the maximum at 8  mg/kg Enbrel 
when litter serum TNF-α was detected (Fig.  1c). In the 
futher research of the function, we found the similar results 
in  TNF-α deleted rats. As  TNF-α was  deficient, the liver 
injury was significantly  aggravated after administration of 
CCl4 (Additional file 1). It might hint that TNF-α had some 
protective effect in the acute liver injury. And its protective 
role was gradually decreased as TNF-α level was declined. 
However, interestingly, the serum ALT and AST were less 
at 0  mg/kg Enbrel used than 8  mg/kg Enbrel. It indicated 
that the extent of hepatocellular damage were slighter at 
high level of TNF-α (0  mg/kg Enbrel) than very low level 
of TNF-α (8  mg/kg Enbrel). Thus, high concentration of 
TNF-α also had some protective role for the hepatocytes in 
the acute liver injury. Furthermore, Hematoxylin and Eosin 
(HE) staining results also showed that the hepatocellular 
steatosis was serious at 0 or 8 mg/kg Enbrel, especially more 
serious at 8 mg/kg Enbrel used in CCl4-induced acute injury 
rats (Fig. 1d). The hepatocellular damage was alleviated at 
1  mg/kg Enbrel used. These results suggested that TNF-α 
might play a dual role in the CCl4-induced liver injury.
The apoptosis of liver cells in acute liver injured rats
Injury is typically associated with changes of apoptosis, 
and TNF-α is also known to link with apoptosis [13], 
which promoted us to study the relationship between 
TNF-α and apoptosis in CCl4-induced rats. To deter-
mine the relationship between hepatocellular apoptosis 
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and TNF-α level, TUNEL assay and the expressions of 
cleaved-caspase-3, an apoptotic protein, were detected 
by immunohistochemistry (Fig.  2a, b). We found there 
were almost no hepatocellular apoptosis during the pro-
cess of increasing doses of Enbrel in the rats without 
administration of CCl4. It indicated that changed TNF-α 
level would not harmful for hepatocytes in the healthy 
rats. However, after the treatment of CCl4, high level of 
TNF-α was obviously increased as well as hepatocellular 
apoptosis at 0  mg/kg Enbrel. Meanwhile, as Enbrel was 
increased to 1  mg/kg, the apoptosis were significantly 
decreased. And they were elevated instead when Enbrel 
was added from 1 to 8  mg/kg. Next, we detected the 
cleaved-caspase3 expression by Western-Blotting. As we 
predicted that cleaved-caspase-3 expression was high at 
0 and 8  mg/kg Enbrel, and was very low at 1  mg/kg in 
CCl4-induced rats. Meantime, it was clearly that expres-
sion of cleaved-caspase3 at 8  mg/kg was stronger than 
0  mg/kg (Fig.  2c). These results further suggested that 
TNF-α had a dual role in the CCl4-induced liver injury. 
Fig. 1 Different levels of internal TNF-α influence on the CCl4-induced acute liver injured model. a Serum ALT and b AST levels were examined 
by Roche Diagnostic kits in Hithachi Modular P Autoanalyser. The levels of ALT and AST were significantly elevated 24 h later after subcutaneous 
injection of 1 ml/kg CCl4 into Sprague–Dawley rats. (ALT: from 36.75 ± 8.73 to 193.27 ± 14.26 U/L; AST: from 150.86 ± 12.34 to 253.79 ± 12.90 U/L. 
p < 0.01). In contrast to the CCl4 group, the ALT and AST levels were all down-regulated as Enbrel were administrated at doses of 0.25, 0.5 and 1 mg/
kg, and elevated again at dose of 2, 4 and 8 mg/kg 15 min before injection of the CCl4. Data were expressed as mean ± SD of seven rats for each 
group. *p < 0.05, **p < 0.01. c ELISA assay of serum TNF-α was notably elevated after CCl4 administered, and gradually decreased as the doses of 
Enbrel were added. d Hematoxylin-eosin–stained liver sections from control and CCl4-induced rats were pretreated with different concentrations 
of Enbrel (scale bar, 100 μm). In the CCl4-induced acute liver injury, the hepatocellular steatosis were serious especially at 0 and 8 mg/kg Enbrel 
treatment, and the structures of hepatic lobule were disorder, companied with hepatocyte degeneration and inflammatory cells infiltrating. In the 
oil-treated rats no matter much Enbrel was pretreated, there were litter hepatocellular steatosis, and the structures of hepatic lobule were clear, with 
few degenerated liver cells and infiltrated inflammatory cells
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Hepatocytes were effectively protected as concentration 
of TNF-α was appropriately reduced, and aggravated as 
TNF-α excessively reduced to a low level.
Internal concentration of TNF‑α had influence 
on expression of inflammatory factors in CCl4‑induced 
acute liver injury
As TNF-α is a potent pro-inflammatory cytokine, and 
injury is often accompanied with inflammation. Then we 
next studied the influence of TNF-α on inflammation in 
CCl4-induced rats. Several inflammatory factors, involve 
IL-4, IL-6, IL-8, IL-β and IFN-γ were detected at different 
concentrations of TNF-α in common and CCl4-induced 
rats. RT-PCR showed that mRNA expressions of inflam-
matory factors were dose-dependent on internal TNF-α 
level in acute liver injury, but litter influence on common 
rats without injection of CCl4, no matter how much the 
level of TNF-α were changed. It implied that decreased 
TNF-α would hardly affect expression of these inflamma-
tory factors in common rats. However, in CCl4-induced 
rats, the expression of IL-6, IL-8, IL-β and IFN-γ were 
decreased as the concentration of TNF-α was blocked 
by increased dose of Enbrel, (Fig.  3a–d) while IL-4 had 
a completely opposite outcome (Fig.  3e). This because 
IL-4 is secreted by Th2 cells, and block Th1 cells produc-
ing IFN-γ,IL-6 and TNF-α [23] et al. It might suggest that 
TNF-α could mediate inflammatory response and pro-
mote expression of inflammatory factors in acute liver 
injury. However, the expression of IL-6, IL-8, IL-β and 
IFN-γ were still inhibited at excessively low level of TNF-
α. It seemed that the protective effect of TNF-α in acute 
injury might be worked though inhibiting pro-inflamma-
tory factors response and increasing anti-inflammatory 
factors. As hepatocellular damage was aggravated at very 
low degree of internal TNF-α level in CCl4-induced liver 
injury. We speculated that limited internal inflamma-
tory factors could hardly protect hepatic cells from dam-
age. But, how did TNF-α arouse excessive inflammatory 
response, and whether there were other mechanisms par-
ticipating in the process of acute liver injury?
TNF‑α mediated acute liver injury may via NF‑κB activation 
and subsequent production of anti‑apoptotic genes
Previous studies have shown that TNF-α played an 
important role in acute liver injury. Considering that 
NF-κB, a crucial transcription factor, is widely accepted 
for regulating inflammation, innate and adaptive immu-
nity [24, 25]. Then, we detected the relative expression 
of NF-κB signal pathway during the process of different 
levels of TNF-α in CCl4-induced liver injury. Western-
blotting results indicated that p-IκBα (Phospho-Inhibitor 
of Inhibitor of KappaB) and NF-κB-p65 production were 
activated in CCl4 model. But they were inhibited as pre-
treatment with Enbrel, while the expression of IκBα had 
an opposite result (Fig. 4a). For IκBα is an inhibitor pro-
tein of NF-κB, spread outside of cell nucleus. Degradation 
of it by phosphorylation could activate NF-κB pathway. 
Meanwhile, we detected subsequent production of anti-
apoptotic gene include Bcl-XL, FHC, XIAP and Bcl-2 in 
the CCl4-induced liver injury. Western-blotting and RT-
PCR results showed that the expression of anti-apoptosis 
genes were declined as TNF-α was blocked by increased 
Enbrel (Fig. 4b, c). It suggested that anti-apoptosis genes 
were also activated in CCl4-induced liver acute injury 
and weakened as the concentration of TNF-α was down 
regulated. These results possibly indicated that TNF-α 
activated NF-κB signal pathway for further stimulat-
ing anti-apoptosis genes in protection of hepatic cells in 
acute liver injury.
Fig. 2 TNF-α influences hepatocellular apoptosis in CCl4-induced 
acute liver injury. a TUNEL assay was performed using and b 
immunohistochemistry analyzed of hepatocellular apoptosis in CCl4-
induced rats with anti-cleaved caspase-3 (magnification ×400). There 
was litter apoptosis as different doses of Enbrel were injected into 
the normal rats. Appropriately reduced TNF-α level would decrease 
hepatocellular apoptosis, and excessively reduced TNF-α level would 
aggravate apoptosis in CCl4-induced-acute liver injury. The arrows 
represented apoptotic cells. c Western-blot analyzed the expres-
sion of hepatocellular apoptosis by detecting cleaved-caspase-3 in 
CCl4-induced rats. Number of apoptotic hepatocytes was reduced 
at appropriately low level of TNF-α, while increased at high and exces-
sive low level of TNF-α in acute liver injured rats. (*p < 0.05, **p < 0.01)
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Discussion
Many studies have focused on the role of TNF-α as a 
cytokine participate the occurrence and development of 
liver injury [11]. Our present study provided experimen-
tal evidences that TNF-α performed protective and dam-
aging effect at the same time in the CCl4-induced acute 
liver injury. For the protective side, our results demon-
strated that the serum ALT and AST at 0 mg/kg Enbrel, 
a genetically engineered fusion protein which can specifi-
cally bind and inactivate TNF-α [22], is less than 8 mg/
kg Enbrel (the highest level) in Fig.  1a, b. Hematoxylin 
and Eosin staining results also showed that the extent of 
hepatocellular steatosis was less at 0 than 8 mg/kg Enbrel 
(Fig.  1d). High level of serum TNF-α was detected at 
0 mg/kg Enbrel, and very low level at 8 mg/kg Enbrel by 
Elisa in CCl4-induced liver injury (Fig. 1c). These results 
indicated that liver damage was slighter at 8 mg/kg Enbrel 
compared to the 0  mg/kg. Therefore, we believed that 
TNF-α had some protective effect in the CCl4-induced 
liver injury. For the damaging side, our results suggested 
that serum ALT and AST were decreased (Fig. 1a, b), as 
the Enbrel was added from 0 to 1  mg/kg in acute liver 
injury. And hepatocellular steatosis was also alleviated in 
this process. These results suggested that TNF-α also had 
some damaging effect in the CCl4-induced liver injury. 
Moreover, the protective effect seemed more prominent 
than the damaging effect at 0 mg/kg Enbrel.
On the account of apoptosis play a significant role in 
the injured tissues [26, 27], and is essential for clearance 
of potentially injurious inflammatory cells and subse-
quent efficient resolution of inflammation [28]. Then, we 
next detected hepatocellular apoptosis at different levels 
Fig. 3 Expressions of inflammatory factors were related with TNF-α. RT-PCR mRNA analysed the expression of a IL-1β, b IFN-γ, c IL-6, d IL-8, and e 
IL-4 in CCl4-induced rats. We set mRNA expression of these inflammatory factors as one in each control groups. (*p < 0.05, **p < 0.01)
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of TNF-α in CCl4-induced liver injured rats. As expected, 
the number of apoptotic hepatocytes were prominently 
decreased as the level of TNF-α was slightly down-reg-
ulated, while elevated at both excessively low and high 
levels of TNF-α (Fig.  2a, b). Meantime, Western-Blot-
ting (Fig.  2c) showed the similar result: the expression 
of hepatocellular apoptosis was weak at 1 mg/kg Enbrel, 
and strong at 0 than 8  mg/kg Enbrel. In addition, the 
expression of apoptosis was stronger at 8 than 0  mg/kg 
Enbrel. These data further demonstrated that TNF-α 
was an indispensable cytokine and played a dual role in 
acute liver injury. Interestingly, in our working, we found 
that the change of liver function presented an obvious 
“V” shape in the whole process of persistently increased 
Enbrel. We speculated that the declined speed of damag-
ing effect of TNF-α was faster than the protective effect 
during the process of persistently increasing Enbrel in 
the CCl4-induced acute liver injury. Initially, as result of 
injurious hepatocytes stimulated by CCl4, TNF-α was 
recruited to repair damaged organization. However, 
too much TNF-α initiated hepatocytes damage instead. 
After Enbrel was increased gradually from 0 to 1 mg/kg, 
TNF-α were decreased (Fig. 1c), and its damaging effect 
had been receded as well as the protective effect. But 
the damaging effect was receded more than the protec-
tive effect. Relatively, the protective effect was prominent 
at the maximum when Enbrel was added at 1  mg/kg, 
which leaded to alleviate the whole extent of liver injury. 
As Enbrel was continually added from 1 to 8 mg/kg, the 
damaging effect and the protective effect of TNF-α were 
further receded. Yet, the extent of protective effect was 
decreased more than its damaging effect. Thus, its pro-
tective effect and damaging effect were declined to the 
maximum and were almost abolished at 8 mg/kg Enbrel. 
Therefore, the injurious hepatocytes caused by CCl4 at 
very low level of TNF-α were more serious than at high 
level. Because the protective effect of TNF-α was almost 
deficient.
However, acute injury is related with inflammatory 
responses [29], which accompany with the change of 
inflammatory factors level. To further investigate the 
reasons for the formation of “V” shape, we detected vari-
ous pro-inflammatory factors including IL-6, IL-8, IL-1β, 
IFN-γ as well as anti-inflammatory factors IL-4 as TNF-α 
was blocked in CCl4-induced acute liver injury. RT-PCR 
indicated the mRNA expressions of IL-6, IL-8, IL-1β and 
Fig. 4 NF-κB signal pathway and anti-apoptotic gene in acute liver injured model. a Western-blot analyzed relevant proteins expression of NF-κB 
pathway include IκBα, p-IκBα and NF-κB-p65 proteins in CCl4-treated rats. The more doses of Enbrel were added, the lower expression of p-IκBα and 
NF-κB-p65 proteins they were, while the expression of IκBα had an opposite effect. b Western-blot and c RT-PCR analyzed anti-apoptosis include 
Bcl-XL, FHC, XIAP and Bcl-2 in CCl4-induced rats. As dose of Enbrel were increased, the expression of anti-apoptosis gene declined. We set mRNA 
expression of these genes as one in each control groups. Data are presented as mean with SD experiments. (*p < 0.05, **p < 0.01)
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IFN-γ were hardly influenced in the common rats no mat-
ter how much Enbrel were pretreated (Fig.  3). However, 
in the acute liver injured rats, these factors were subse-
quently decreased when TNF-α was blocked, while IL-4 
had a completely adverse change. This because IL-4, as 
an anti-inflammatory factor, is secreted by Th2 cell [30], 
and can inhibit Th1 cell producing IFN-γ, IL-6, TNF-α 
et  al. [23]. Yet, relevant pro-inflammatory factors were 
decreased and meanwhile anti-inflammatory factors were 
correspondingly increased in the process of increasing 
Enbrel into CCl4-inducced rats. Therefore, we speculated 
that excessively inflammatory factors were recruited and 
destroyed the defensive system at 0 mg/kg Enbrel in acute 
CCl4-induced liver injured rats. Next, reduction of TNF-α 
could decline pro-inflammatory factors, then weakened 
hepatocytes damage from strong inflammatory response 
in acute injury. However, a certain concentration of 
inflammation is required for the activation of innate and 
adaptive immunity, which is essential for host defense [31, 
32]. As TNF-α was blocked at high dose of Enbrel, pro-
inflammatory factors were hardly detected. Although the 
damaging effect were almost abolished. But, the protec-
tive effect was also deficient, which might result in more 
serious hepatocellular damage. However, how did TNF-α 
and inflammatory factors exert the protective effect in the 
process of increasing Enbrel in the acute liver injury?
Some literatures have reported that the stimulation 
of TNF-α initiates a cascade of signaling events, which 
lead to the activation of NF-κB [24], whose signal path-
way make an essential contribution to liver homeosta-
sis and wound-healing processes [9, 33, 34]. Then, we 
further detected relative expressions of NF-κB and its 
subsequent productions by Western-Blotting in our 
study. It was excitedly that we discovered the expres-
sions of NF-κB and subsequent production were gradu-
ally decreased as Enbrel was increased, and were hardly 
detected at 8  mg/kg Enbrel. Furthermore, our results 
showed that consistently down-regulated TNF-α concen-
tration accompanied with declining of the expressions of 
antiapoptotic genes include Bcl-XL, FHC, XIAP, Bcl-2, 
all of which have protective effects. And their decreased 
extents were also dose-dependent on Enbrel. It indicated 
that NF-κB played a significantly role and its effect was 
gradually declined as well as anti-apoptotic genes, when 
the concentration of TNF-α was blocked by Enbrel in 
the CCl4-induced acute liver injury. Above of these find-
ings, We speculated that the protective effect of TNF-α 
was emerged though NF-κB signal pathway, which fur-
ther activated the antiapoptotic genes include Bcl-XL, 
FHC, XIAP, Bcl-2 et al., then take the protective role for 
the hepatocytes in the CCl4-induced acute liver injury. 
As TNF-α was blocked by Enbrel, its protective effect 
gradually decreased. In the initiate stage, subcutaneous 
injection of CCl4 into rats caused acute hepatocellu-
lar damage by its production of cytochrome P450 and 
the binding reaction with intermediate metabolites. 
Too much TNF-α and pro-inflammatory factors were 
recruited to the injured hepatocytes, then activated over-
expression of NF-κB signal pathway, which further acti-
vated antiapoptotic genes to defend acute liver injury. 
As concentration of TNF-α was appropriately decreased 
from 0 to 1 mg/kg Enbrel, NF-κB was gradually weakened 
and the antiapoptotic genes were also activated slackly. 
However, the hepatocellular damage from CCl4 always 
existed as well as the damaging effect from TNF-α and 
inflammatory response. And the protective effect was a 
bit stronger than the damaging effect of TNF-α, mean-
while, its decreased speed was slower than the damaging 
effect. Thus, the whole of the hepatocellular damage was 
alleviated, and to the minimum at 1 mg/kg Enbrel. As the 
concentration of TNF-α was sequentially decreased from 
1 to 8 mg/kg Enbrel, the protective effect from the NF-κB 
and antiapoptotic gene were continuously decreased. 
Meanwhile, the damaging effect resulted from TNF-α 
and inflammatory response was also weakened. In addi-
tion, the protective effect was declined faster than the 
damaging effect, and these effects were almost abolished 
at 8 mg/kg Enbrel. Thus, the hepatocellular damage was 
further aggravated at 8  mg/kg Enbrel, even was more 
serious than at 0 mg/kg Enbrel. Concurrently, the antia-
poptotic genes were gradually down-regulated as TNF-α 
was consistently blocked by Enbrel (Fig. 4b, c), as result 
of the NF-κB was down-regulated. However, the hepa-
tocellular damage induced by CCl4 was almost existed, 
and the damaging extent was the lightest at 1  mg/kg 
Enbrel, the most at 8 mg/kg Enbrel due to the change of 
the concentration of TNF-α. Thus, the number of apop-
totic hepatocytes was the least at 1 mg/kg Enbrel, and the 
most at 8 mg/kg Enbrel (Fig. 2a, b). As the result of the 
protective effect of TNF-α, the hepatocellular apoptosis 
were slighter at 0 than at 8 mg/kg.
Our findings are clinically relevant, because moderately 
decrease internal TNF-α level can effectively protect 
liver from acute injury. But consistently down-regulated 
TNF-α level seems not a good choice for the treatment 
of acute liver injury. Meanwhile, present data shed novel 
mechanism on understanding different concentrations 
of role activating in acute liver injury caused by CCl4 
and provide new conceptual information for therapeutic 
development of acute liver injury though properly reduc-
ing internal TNF-α level.
Methods
Animal models and treatment
All procedures involving animals were performed 
in accordance with the institutional animal welfare 
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guidelines of Second Military Medical University and 
approved by the Ethics Committee of Eastern Hepato-
biliary Surgery Hospital (Ethics Committee Approved 
Code:EHBHKY2012-002-7).
100 six  weeks old Sprague–Dawley male rats (200–
210  g) were purchased from Shanghai Experimental 
Animal Center of the Chinese Academy of Sciences, 
Shanghai, China. They were kept in ordinary cages at 
room temperature of 25  ±  3  °C with a 12  h dark/light 
cycles, and have free access to standard laboratory feed 
and water. To study the effects of TNF-α in acute injured 
rats, they were equally divided into nine groups (10 rats 
per group). CCl4 (1  ml/kg) was subcutaneously injected 
into Sprague–Dawley rats. Enbrel at dose of 0, 0.25, 0.5, 
1, 2, 4 or 8 mg/kg was intraperitoneally administered to 
the CCl4-injected rats 15 min before the CCl4 injection. 
24 h later, all the animals were weighted, sacrificed, col-
lected the blood while livers were removed, weighted and 
perfuse in ice-cold saline solution. Liver samples were 
treated with liquid nitrogen and stored at −80 °C for fur-
ther studies.
Serum ALT, AST and TNF‑α assay
Serum activities of ALT and aspartate aminotransferase 
(AST) were measured with an autoanalyzer (Spotchem 
Co., Kyoto, Japan). Serum levels of TNF-α in rats were 
measured by enzyme-linked immunosorbent assay 
(ELISA) using the Immunotech Human TNF-α ELISA 
kit (Immunotech SAS, Marseille Cedex 9, France). The 
results are expressed as U/L.
Hematoxylin–eosin staining and TUNEL assay of liver 
sections
Liver tissues for histopathological examination were 
fixed with 10 % neutral buffered formalin, processed and 
trimmed, embedded in paraffin, sectioned to a thickness 
of approximately 5  μm, liver sections were stained with 
HE following standard protocol, then it was performed 
for light microscopic examination. TUNEL assay was 
performed using the In Situ Cell Death Detection kit 
(Roche Molecular Biochemicals).
Immunohistochemistry
Quantitatively measure the expression of cleaved cas-
pase-3 by immunohistochemical staining. Liver tissues 
were fixed in Carnoy, embedded in paraffin, and sec-
tioned at 5 μm. The sections of tissues were dewaxed and 
rehydrated with freshly distilled water. Samples under-
went inactivation of endogenous peroxidase for 10  min 
and were washed with distilled water for 5  min (three 
times), then immersed in 0.1  mol/L citrate buffer solu-
tion (pH  =  6.0) and heated in a microwave oven until 
boiling (twice, with a 5-minute interval). After washed 
with phosphate buffered saline, antigen-retrieval buff-
ers were added for 10 min and tissues were then flushed 
three times with PBS. At room temperature, samples 
were non-specifically blocked with normal goat serum 
for 20  min. Sections were incubated overnight at 4  °C 
with rabbit anti-human cleaved caspase-3 antibody. Sec-
tions were washed in PBS and incubated at room temper-
ature for 10  min with biotinylated goat anti-rabbit IgG. 
After washing with PBS, sections were incubated with 
streptavidin-peroxidase for 10 min and then stained with 
diaminobenzidine for 10 min and washed for 5 min. Sam-
ples were stained with hematoxylin, and were dehydrated 
and mounted for microscopic examination. Images of 
the sections were obtained using the Image-Pro Plus 4.5 
software (Media Cybernetics, Silver. Spring, USA) with 
brown staining under light microscopy indicating a posi-
tive reaction of cleaved caspase-3.
Western‑blot analysis
Total soluble proteins extraction from liver tissue and 
western-blot analysis were performed as described. Anti-
bodies used in western-blot experiments were specific 
for cleaved caspase-3, IκBα (inhibitor of NF-kappa B-α), 
p-IκBα (Phospho-IκBα), BCL-2 (B cell leukemia/lym-
phoma 2), BCL-XL (B-cell lymphoma-extra large), XIAP 
(X-linked Inhibitor of Apoptosis Protein), FHC (Ferri-
tin heavy chain), β-actin and goat anti-rabbit secondary 
antibody were obtained from Cell Signaling Technology. 
NFκB-p65 antibody was obtained from Abcam.
RT‑PCR analysis
The transcript levels of FHC, Bcl-XL, Bcl-2, XIAP, TNF-α, 
IL-1β, IFN-, IL-6, IL-8 and IL-4 in liver tissues of rats were 
measured using RT-PCR technique. Total RNA was iso-
lated using the TriPure reagent (Roche Diagnostics), RNA 
concentrations and purity were determined by measuring 
the absorbance A260–A280 nm ratio. The relative quan-
tities of mRNAs were obtained by using the comparative 
Ct method and were normalized with glyceraldehydes-
3-phosphate dehydrogenase (GAPDH). The primer 
sequences were as following: FHC: Forward primer 
5′-CCACGTGACCAACTTACGC-3′, Reverse primer 
5′-AGTCAGCTTATCTCTCATCACCG-3′; Bcl-XL: For-
ward primer 5′-TCCCTTCAGAACCTTATCTTGG-3′, 
Reverse primer 5′-TCCCGGAAGAGTTCATTCAC-3′; 
Bcl-2: Forward primer 5′-ACAGCCAGGAGAAAT 
CAAA-3′, Reverse primer 5′-GTCGCTACCGTCGT 
GACTTC-3′; XIAP: Forward primer 5′-CTGCATTG 
CATTCCATTAGC-3′, Reverse primer 5′-TGCTTCTCT 
GTCTAAGGTTTCAA-3′; TNF-α: Forward primer 
5′-TTCTGTCTACTGAACTTGGGGGTGATCGGTC 
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C-3′, Reverse primer 5′-GTATGAGATAGCAAATCGG 
CTGACGGTGTGGG-3′; IL-1β: Forward primer 5′-GGC 
TGCTTCCAAACCTTTGA-3′, Reverse primer 5′-GAA 
GACACGGATTCCATGGT-3′; IL-6: Forward primer 
5′-ATGAAGTTCCTCTCTGCAAGAGAC-3′, Reverse 
primer 5′-CACTAGGTTTGCCGAGTAGATCTC-3′; 
IL-8: Forward primer 5′-AATTCTCGAGTCGCGAATG 
GCTGCTCAAGGCTG-3′, Reverse primer 5′-ATTACG 
GCCGTCGCGATTAGGCATCACTGCCTG-3′.
Statistical analysis
All data are presented as mean  ±  SEM. Groups were 
compared by analysis of variance (ANOVA) with a poste-
riori contrast by least significant difference. For all analy-
ses, p < 0.05 was considered statistically significant.
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Additional file
 Additional file 1. Liver injury was aggravated in the CCl4-induced rats 
of TNF-α deficiency. (A) Gene sequencing diagram suggested TNF-α was 
successfully deleted by crispr/cas9 technique. Obviously, the five basic 
groups were deficient during the 205–210 gene segment of TNF-α−/− rat. 
(B) Serum ALT and (C) AST levels were examined by Roche Diagnostic 
kits in Hithachi Modular P Autoanalyser. The levels of ALT and AST were 
significantly elevated 24 h later after 1 ml/kg CCl4 was subcutaneously 
injected into Sprague–Dawley rats 24 h later (***p < 0.001). In the TNF-
α−/− rats, serum of ALT and AST were elevated more than the TNF-α+/+ 
rats (*p < 0.01). (D) Hematoxylin-eosin–stained of liver paraffin sections 
analyzed that there was almost no hepatocellular steatosis in the rats 
without treatment of CCl4. And the steatosis was almost distributed all 
over the field of vision in the TNF-α−/− rats. It was more serious than the 
TNF-α+/+ rats.
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